BeyondSpring Financials

Earnings View

Profitability View

Liquidity View

Fundamentals View

Competition View

BeyondSpring Stock Summary

BeyondSpring competes with Aptevo Therapeutics, DiaMedica Therapeutics, Marker Therapeutics, Fulcrum Therapeutics, and NRX Pharmaceuticals. BeyondSpring Inc., a clinical stage biopharmaceutical company, together with its subsidiaries, focuses on the development of cancer therapies. The company was founded in 2010 and is headquartered in New York, New York. Beyondspring operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 103 people.

BeyondSpring Key Financial Ratios

BeyondSpring Key Balance Sheet Accounts

BeyondSpring Key Income Statement Accounts

BeyondSpring Key Cash Accounts

BeyondSpring Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining BeyondSpring's current stock value. Our valuation model uses many indicators to compare BeyondSpring value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across BeyondSpring competition to find correlations between indicators driving BeyondSpring's intrinsic value. More Info.BeyondSpring is rated fifth in return on equity category among its peers. It is rated third in return on asset category among its peers . As of now, BeyondSpring's Return On Equity is increasing as compared to previous years. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the BeyondSpring's earnings, one of the primary drivers of an investment's value.

BeyondSpring Systematic Risk

Today, most investors in BeyondSpring Stock are looking for potential investment opportunities by analyzing not only static indicators but also various BeyondSpring's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of BeyondSpring growth as a starting point in their analysis.

Along with financial statement analysis, the daily predictive indicators of BeyondSpring help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of BeyondSpring. We use our internally-developed statistical techniques to arrive at the intrinsic value of BeyondSpring based on widely used predictive technical indicators. In general, we focus on analyzing BeyondSpring Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build BeyondSpring's daily price indicators and compare them against related drivers.

When running BeyondSpring's price analysis, check to measure BeyondSpring's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BeyondSpring is operating at the current time. Most of BeyondSpring's value examination focuses on studying past and present price action to predict the probability of BeyondSpring's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BeyondSpring's price. Additionally, you may evaluate how the addition of BeyondSpring to your portfolios can decrease your overall portfolio volatility.